JP2017214420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017214420A5 JP2017214420A5 JP2017159116A JP2017159116A JP2017214420A5 JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5 JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- composition
- dash inhibitor
- group
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161562497P | 2011-11-22 | 2011-11-22 | |
| US61/562,497 | 2011-11-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Division JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017214420A JP2017214420A (ja) | 2017-12-07 |
| JP2017214420A5 true JP2017214420A5 (https=) | 2018-02-08 |
Family
ID=48470210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
| JP2017159116A Pending JP2017214420A (ja) | 2011-11-22 | 2017-08-22 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9284337B2 (https=) |
| EP (2) | EP2782994B1 (https=) |
| JP (2) | JP6240083B2 (https=) |
| CN (2) | CN106075450A (https=) |
| AU (2) | AU2012340887A1 (https=) |
| CA (1) | CA2856379A1 (https=) |
| HK (1) | HK1201871A1 (https=) |
| IL (1) | IL232664A0 (https=) |
| WO (1) | WO2013078059A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013078059A1 (en) * | 2011-11-22 | 2013-05-30 | Trustees Of Tufts College | Small molecule enhancer for dendritic cell cancer vaccines |
| JP2018500299A (ja) | 2014-11-25 | 2018-01-11 | バイオエクセル コーポレーション | 神経線維腫症２型に関連する腫瘍の治療のためのユビキチン−プロテアソーム系阻害剤の使用 |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| US11000521B2 (en) | 2015-08-03 | 2021-05-11 | Institut Pasteur | Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy |
| US11583516B2 (en) * | 2016-09-07 | 2023-02-21 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| WO2018187698A2 (en) * | 2017-04-07 | 2018-10-11 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists |
| US11559537B2 (en) | 2017-04-07 | 2023-01-24 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists |
| JP2019208422A (ja) * | 2018-06-04 | 2019-12-12 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040145A (en) * | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| WO2000010549A1 (en) * | 1998-08-21 | 2000-03-02 | Point Therapeutics, Inc. | Regulation of substrate activity |
| AU781897B2 (en) * | 1999-05-25 | 2005-06-23 | Point Therapeutics, Inc. | Anti-tumor comprising boroproline compounds |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| CN100392074C (zh) * | 2003-10-15 | 2008-06-04 | 上海海欣生物技术有限公司 | 树突状细胞肿瘤疫苗及其制法和用途 |
| US7998997B2 (en) * | 2005-07-05 | 2011-08-16 | Trustees Of Tufts College | Inhibitors of fibroblast activation protein alpha |
| JP5270369B2 (ja) * | 2005-12-19 | 2013-08-21 | タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ | ソフトプロテアーゼ抑制剤およびそのプロソフト型 |
| WO2007123686A2 (en) * | 2006-03-31 | 2007-11-01 | Point Therapeutics, Inc. | Dpp inhibitors and uses thereof |
| WO2008116054A1 (en) * | 2007-03-20 | 2008-09-25 | Trustees Of Tufts College | Inhibitors of fibroblast activation protein, and methods of use thereof |
| KR101506751B1 (ko) * | 2007-05-17 | 2015-03-27 | 디나벡크 가부시키가이샤 | 수상세포의 제조방법 |
| DK2176408T5 (en) * | 2008-01-31 | 2015-12-14 | Curevac Gmbh | Nucleic acids comprising FORMULA (NuGiXmGnNv) a AND DERIVATIVES AS IMMUNE STIMULATING AGENTS / ADJUVANTS. |
| WO2013078059A1 (en) * | 2011-11-22 | 2013-05-30 | Trustees Of Tufts College | Small molecule enhancer for dendritic cell cancer vaccines |
-
2012
- 2012-11-15 WO PCT/US2012/065236 patent/WO2013078059A1/en not_active Ceased
- 2012-11-15 JP JP2014543501A patent/JP6240083B2/ja active Active
- 2012-11-15 HK HK15102280.8A patent/HK1201871A1/xx unknown
- 2012-11-15 AU AU2012340887A patent/AU2012340887A1/en not_active Abandoned
- 2012-11-15 CN CN201610493117.7A patent/CN106075450A/zh active Pending
- 2012-11-15 CA CA2856379A patent/CA2856379A1/en not_active Abandoned
- 2012-11-15 EP EP12850873.6A patent/EP2782994B1/en active Active
- 2012-11-15 US US14/353,408 patent/US9284337B2/en active Active
- 2012-11-15 EP EP16180971.0A patent/EP3106173A1/en not_active Withdrawn
- 2012-11-15 CN CN201280067478.5A patent/CN104039952A/zh active Pending
-
2014
- 2014-05-18 IL IL232664A patent/IL232664A0/en unknown
-
2015
- 2015-11-23 US US14/948,777 patent/US9839646B2/en active Active
-
2017
- 2017-08-22 JP JP2017159116A patent/JP2017214420A/ja active Pending
- 2017-11-20 US US15/817,754 patent/US20180092933A1/en not_active Abandoned
-
2018
- 2018-06-25 AU AU2018204591A patent/AU2018204591A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017214420A5 (https=) | ||
| JP2014533727A5 (https=) | ||
| JP7355758B2 (ja) | ケモカイン受容体調節剤及びその使用 | |
| US10106581B2 (en) | Cyclic peptidomimetic compounds as immunomodulators | |
| ES2539603T3 (es) | Agente inductor de inmunidad | |
| US9776978B2 (en) | 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators | |
| US9839646B2 (en) | Small molecule enhancer for dendritic cell cancer vaccines | |
| JP2017536344A5 (https=) | ||
| JP2017519753A5 (https=) | ||
| JP2020508310A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| JP2016534059A5 (https=) | ||
| JP2018504379A5 (https=) | ||
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| CN111918652A (zh) | 用于治疗eb病毒阳性的癌症的趋化因子受体调节剂 | |
| JP5201995B2 (ja) | ジアザベンゾ［デ］アントラセン−３−オン化合物、及び、ｐａｒｐの阻害方法 | |
| JP2018516994A5 (https=) | ||
| JP2008506710A5 (https=) | ||
| JP2005508857A5 (https=) | ||
| JP2014532751A5 (https=) | ||
| KR102275112B1 (ko) | 5-브로모-인디루빈 | |
| TWI796326B (zh) | 含有ａｘｌ抑制劑與ｅｇｆｒ酪胺酸激酶抑制藥的醫藥品及其用途 | |
| JP2017509672A5 (https=) | ||
| JP2009527463A5 (https=) | ||
| JP2023514426A5 (https=) |